Medical Developments International Limited
MDDVF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $19 | $20 | $18 | $15 |
| % Growth | -4.6% | 10.6% | 19.8% | – |
| Cost of Goods Sold | $4 | $5 | $15 | $21 |
| Gross Profit | $15 | $15 | $3 | -$5 |
| % Margin | 77.1% | 73.6% | 16.3% | -36.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $12 | $10 | $26 | $6 |
| SG&A Expenses | $14 | $12 | $28 | $8 |
| Sales & Mktg Exp. | $2 | $2 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | -$21 | $0 |
| Operating Expenses | $14 | $12 | $7 | $8 |
| Operating Income | $0 | $3 | -$4 | -$13 |
| % Margin | 2% | 13.5% | -21.4% | -86.2% |
| Other Income/Exp. Net | -$1 | -$2 | -$16 | $0 |
| Pre-Tax Income | -$0 | $0 | -$20 | -$13 |
| Tax Expense | $0 | $0 | $10 | -$2 |
| Net Income | -$0 | $0 | -$30 | -$11 |
| % Margin | -1.1% | 1.5% | -166.3% | -72.6% |
| EPS | -0.002 | 0.003 | -0.34 | -0.12 |
| % Growth | -170.4% | 100.8% | -183.3% | – |
| EPS Diluted | -0.002 | 0.003 | -0.34 | -0.12 |
| Weighted Avg Shares Out | 110 | 113 | 89 | 89 |
| Weighted Avg Shares Out Dil | 113 | 113 | 89 | 89 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | $2 | $2 | $2 |
| EBITDA | -$1 | $3 | -$18 | -$11 |
| % Margin | -5.4% | 13.5% | -100.9% | -74.4% |